These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15485615)

  • 1. Proteomics in cancer screening and management in gynecologic cancer.
    Hu W; Wu W; Kobayashi R; Kavanagh JJ
    Curr Oncol Rep; 2004 Nov; 6(6):456-62. PubMed ID: 15485615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics and islet research.
    Ahmed M
    Adv Exp Med Biol; 2010; 654():363-90. PubMed ID: 20217506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometry as a tool for biomarkers searching in gynecological oncology.
    Banach P; Suchy W; Dereziński P; Matysiak J; Kokot ZJ; Nowak-Markwitz E
    Biomed Pharmacother; 2017 Aug; 92():836-842. PubMed ID: 28601044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic strategies for the characterization and the early detection of lung cancer.
    Massion PP; Caprioli RM
    J Thorac Oncol; 2006 Nov; 1(9):1027-39. PubMed ID: 17409991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
    Jimenez CR; Verheul HM
    Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic diagnosis competition: design, concepts, participants and first results.
    Mertens BJ
    J Proteomics; 2009 Jul; 72(5):785-90. PubMed ID: 19375529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets.
    Boyce EA; Kohn EC
    Int J Gynecol Cancer; 2005; 15 Suppl 3():266-73. PubMed ID: 16343243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising directions for the diagnosis and management of gynecological cancers.
    Kohn EC; Mills GB; Liotta L
    Int J Gynaecol Obstet; 2003 Oct; 83 Suppl 1():203-9. PubMed ID: 14763176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industrial-scale proteomics analysis of human plasma.
    Rose K
    Methods Biochem Anal; 2005; 45():217-29. PubMed ID: 19235297
    [No Abstract]   [Full Text] [Related]  

  • 11. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer: can proteomics give new insights for therapy and diagnosis?
    Toss A; De Matteis E; Rossi E; Casa LD; Iannone A; Federico M; Cortesi L
    Int J Mol Sci; 2013 Apr; 14(4):8271-90. PubMed ID: 23591842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optomechanical devices for deep plasma cancer proteomics.
    Kosaka PM; Calleja M; Tamayo J
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer.
    Ryu J; Thomas SN
    Molecules; 2021 May; 26(9):. PubMed ID: 34063568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer proteomics: Serum diagnostics for tumor marker discovery.
    Rai AJ; Chan DW
    Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
    Krieg RC; Paweletz CP; Liotta LA; Petricoin EF
    Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of proteomics and its applications in cancer.
    Chuthapisith S; Layfield R; Kerr ID; Eremin O
    Surgeon; 2007 Feb; 5(1):14-22. PubMed ID: 17313124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to Clinical Proteomics.
    Wiktorowicz JE; Brasier AR
    Adv Exp Med Biol; 2016; 919():435-441. PubMed ID: 27975229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ongoing evolution of proteomics in malignancy.
    Dhamoon AS; Kohn EC; Azad NS
    Drug Discov Today; 2007 Sep; 12(17-18):700-8. PubMed ID: 17826682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.